GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Sold by Webster Bank N. A.

Webster Bank N. A. trimmed its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 50.7% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 404 shares of the company’s stock after selling 416 shares during the quarter. Webster Bank N. A.’s holdings in GE HealthCare Technologies were worth $37,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Jennison Associates LLC raised its stake in shares of GE HealthCare Technologies by 49.4% during the 4th quarter. Jennison Associates LLC now owns 1,208,830 shares of the company’s stock worth $93,467,000 after buying an additional 399,961 shares during the period. South Dakota Investment Council increased its position in shares of GE HealthCare Technologies by 272.1% during the fourth quarter. South Dakota Investment Council now owns 98,262 shares of the company’s stock worth $7,598,000 after purchasing an additional 71,857 shares in the last quarter. US Bancorp DE increased its position in shares of GE HealthCare Technologies by 83.4% during the fourth quarter. US Bancorp DE now owns 146,524 shares of the company’s stock worth $11,329,000 after purchasing an additional 66,638 shares in the last quarter. Cerity Partners LLC increased its position in shares of GE HealthCare Technologies by 27.2% during the fourth quarter. Cerity Partners LLC now owns 45,929 shares of the company’s stock worth $3,551,000 after purchasing an additional 9,809 shares in the last quarter. Finally, Fifth Third Bancorp increased its position in shares of GE HealthCare Technologies by 3.9% during the fourth quarter. Fifth Third Bancorp now owns 33,632 shares of the company’s stock worth $2,600,000 after purchasing an additional 1,250 shares in the last quarter. 82.06% of the stock is owned by institutional investors and hedge funds.

Insider Buying and Selling at GE HealthCare Technologies

In other news, CTO Taha Kass-Hout sold 3,300 shares of the stock in a transaction dated Tuesday, May 28th. The stock was sold at an average price of $78.70, for a total value of $259,710.00. Following the transaction, the chief technology officer now owns 67,300 shares in the company, valued at approximately $5,296,510. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. In related news, CEO Jan Makela sold 66,955 shares of the firm’s stock in a transaction that occurred on Wednesday, May 15th. The stock was sold at an average price of $81.54, for a total transaction of $5,459,510.70. Following the transaction, the chief executive officer now owns 63,348 shares in the company, valued at approximately $5,165,395.92. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CTO Taha Kass-Hout sold 3,300 shares of GE HealthCare Technologies stock in a transaction that occurred on Tuesday, May 28th. The shares were sold at an average price of $78.70, for a total value of $259,710.00. Following the completion of the transaction, the chief technology officer now owns 67,300 shares in the company, valued at $5,296,510. The disclosure for this sale can be found here. Insiders have sold 90,482 shares of company stock valued at $7,369,137 in the last quarter. Corporate insiders own 0.27% of the company’s stock.

Analysts Set New Price Targets

Several brokerages recently commented on GEHC. Citigroup boosted their price target on GE HealthCare Technologies from $88.00 to $103.00 and gave the stock a “buy” rating in a research report on Wednesday, April 3rd. Argus upped their target price on GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a report on Monday, April 1st. The Goldman Sachs Group initiated coverage on GE HealthCare Technologies in a report on Thursday, May 30th. They issued a “neutral” rating and a $87.00 target price for the company. Mizuho dropped their target price on GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating for the company in a report on Wednesday, May 1st. Finally, Evercore ISI increased their price target on GE HealthCare Technologies from $93.00 to $100.00 and gave the stock an “outperform” rating in a report on Thursday, April 4th. Five investment analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $94.09.

GE HealthCare Technologies Trading Down 1.1 %

GEHC traded down $0.90 during mid-day trading on Friday, hitting $77.92. 9,422,475 shares of the stock were exchanged, compared to its average volume of 2,701,271. The firm’s fifty day moving average is $79.85 and its two-hundred day moving average is $81.73. GE HealthCare Technologies Inc. has a 1-year low of $62.35 and a 1-year high of $94.50. The company has a current ratio of 1.06, a quick ratio of 0.83 and a debt-to-equity ratio of 1.11. The company has a market cap of $35.57 billion, a PE ratio of 22.78, a PEG ratio of 2.83 and a beta of 1.22.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings results on Tuesday, April 30th. The company reported $0.90 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.90. The company had revenue of $4.65 billion for the quarter, compared to analyst estimates of $4.80 billion. GE HealthCare Technologies had a return on equity of 25.32% and a net margin of 8.05%. GE HealthCare Technologies’s revenue for the quarter was down 1.2% compared to the same quarter last year. During the same quarter last year, the company earned $0.85 EPS. Equities analysts forecast that GE HealthCare Technologies Inc. will post 4.27 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Thursday, August 15th. Shareholders of record on Friday, July 19th will be given a $0.03 dividend. This represents a $0.12 dividend on an annualized basis and a yield of 0.15%. The ex-dividend date is Friday, July 19th. GE HealthCare Technologies’s dividend payout ratio is currently 3.51%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.